COGNITION THERAPEUTICS INC cotiza a 0.80 USD y tiene una capitalización bursátil de $76M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally delivered small molec…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-0.04 | $-0.05 | $-0.02 | — |
| Estimado | $-0.06 | $-0.07 | $-0.08 | $-0.11 |
| Sorpresa | +33.3% | +28.6% | +75.0% | — |
| Métrica | CGTX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -68.5% | -40.4% | -28.1% |
| ROA | -48.5% | -32.0% | -16.5% |
| Current Ratio | 3.45 | 2.84 | +0.61 |
| Debt / Equity | — | 0.28 | — |